These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5030935)

  • 1. Fibrin-stabilizing factor inhibitors. 5. Primary amines related to monotosylcadaverine.
    Stenberg P; Ljunggren C; Nilsson JL; Lundén R; Eriksson O
    J Med Chem; 1972 Jun; 15(6):674-5. PubMed ID: 5030935
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrin-stabilizing factor inhibitors. II. The inhibitory properties of various aliphatic amines.
    Stenberg P; Nilsson JL; Eriksson O; Lundén R
    Acta Pharm Suec; 1971 Sep; 8(4):415-22. PubMed ID: 5135175
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrinoligase: the fibrin-stabilizing factor system of blood plasma.
    Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():6-30. PubMed ID: 4565370
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrin-stabilizing factor inhibitors. 12. 5-Dibenzylaminopentylamine and related compounds, a new type of FSF inhibitors.
    Hoffmann KJ; Stenberg P; Ljunggren C; Svensson U; Nilsson JL
    J Med Chem; 1975 Mar; 18(3):278-84. PubMed ID: 1133818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and unusual reactivity of N-tosyl-4,5-benzoazacyclodeca-2,6-diyne, yneamino-containing enediyne.
    Poloukhtine A; Popik VV
    J Am Chem Soc; 2007 Oct; 129(40):12062-3. PubMed ID: 17877347
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrin-stabilizing factor inhibitors.
    Nilsson JL; Stenberg P; Ljunggren C; Hoffman KJ; Lundén R; Eriksson O; Lorand L
    Ann N Y Acad Sci; 1972 Dec; 202():286-96. PubMed ID: 4508928
    [No Abstract]   [Full Text] [Related]  

  • 7. The action of Arvin on Fibrin Stabilizing Factor (factor 13).
    Barlow GH; Holleman WH; Lorand L
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):39-42. PubMed ID: 5535658
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimalarial agents. 8. Ring-substituted bis(4-aminophenyl) sulfones and their precursors.
    Popoff IC; Engle AR; Whitaker RL; Singhal GH
    J Med Chem; 1971 Dec; 14(12):1166-9. PubMed ID: 5116228
    [No Abstract]   [Full Text] [Related]  

  • 9. Fibrin-stabilizing factor inhibitors. 3. Sulphonamides related to monodansylcadaverine.
    Nilsson JL; Stenberg P; Ljunggren C; Eriksson O; Lundén R
    Acta Pharm Suec; 1971 Nov; 8(5):497-504. PubMed ID: 5159519
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrin-stabilizing factor inhibitors. 4. Action of some synthetic fibrinoligase inhibitors on human platelet aggregation.
    Lundén R; Hartkoorn A; Nilsson JL; Stenberg P; Bruner-Lorand J; Lorand L
    J Med Chem; 1972 Jan; 15(1):98-9. PubMed ID: 5007105
    [No Abstract]   [Full Text] [Related]  

  • 11. An inhibitor to fibrin stabilizing factor (FSF, factor XIII).
    Godal HC
    Scand J Haematol; 1970; 7(1):43-8. PubMed ID: 5447956
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel approach for asymmetric synthesis of fluorinated beta-amino sulfones and allylic amines.
    Fustero S; Soler JG; Bartolomé A; Roselló MS
    Org Lett; 2003 Jul; 5(15):2707-10. PubMed ID: 12868895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin-stabilizing factor inhibitors. 8. Pyridine derivatives as charge-transfer complex acceptors.
    Nilsson JL; Hoffmann KJ; Ljunggren C; Stenberg P; Svensson U; Eriksson O; Lundén R
    Acta Pharm Suec; 1973 Jun; 10(3):209-14. PubMed ID: 4729697
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrin-stabilizing factor inhibitors. 11. Monodansylated weak aliphatic diamines.
    Ljunggren C; Hoffmann KJ; Stenberg P; Svensson U; Nilsson JL; Hartkoorn A; Lundén R
    J Med Chem; 1974 Jun; 17(6):649-51. PubMed ID: 4829944
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrin-stabilizing factor inhibitors. 10. Thiol esters as potent enzyme inhibitors.
    Ljunggren C; Hoffmann KJ; Stenberg P; Nilsson JL
    J Med Chem; 1973 Oct; 16(10):1186-8. PubMed ID: 4749477
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of [4-[4-(methylsulfonyl)phenyl]-6-(trifluoromethyl)-2-pyrimidinyl] amines and ethers as potent and selective cyclooxygenase-2 inhibitors.
    Swarbrick ME; Beswick PJ; Gleave RJ; Green RH; Bingham S; Bountra C; Carter MC; Chambers LJ; Chessell IP; Clayton NM; Collins SD; Corfield JA; Hartley CD; Kleanthous S; Lambeth PF; Lucas FS; Mathews N; Naylor A; Page LW; Payne JJ; Pegg NA; Price HS; Skidmore J; Stevens AJ; Stocker R; Stratton SC; Stuart AJ; Wiseman JO
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4504-8. PubMed ID: 19520573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII deficiency in BALB/c mice with plasmacytoma.
    Eipe J; Yakulis V; Costea N
    Cancer Res; 1977 Oct; 37(10):3551-5. PubMed ID: 908006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrin-stabilizing factor inhibitors. IX. An inhibitor assay method based on SDS-disc gel electrophoresis.
    Hoffmann KJ; Ljunggren C; Stenberg P; Nilsson JL
    Acta Pharm Suec; 1973 Sep; 10(4):269-76. PubMed ID: 4759353
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid).
    Nilsson JL; Stenberg P; Eriksson O; Lundén R
    Acta Pharm Suec; 1970 Sep; 7(4):441-8. PubMed ID: 5480084
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factor XIII-heparin complex and its properties as a physiological solvent for unstabilized fibrin].
    Ul'ianov AM; Kudriashov BA
    Vopr Med Khim; 1975; 21(1):19-23. PubMed ID: 235172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.